Form 8-K · Current report
GE HealthCare 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000045
Summary
GE HealthCare reported second-quarter 2026 revenue of $5.3 billion, up 5.7% year over year with 3.5% organic growth, net income of $561 million and diluted EPS of $1.24, and reaffirmed its full-year 2026 guidance of 3.0%–4.0% organic revenue growth and adjusted EPS of $4.80–$5.00. CEO Peter Arduini said the quarter delivered record orders and backlog with growth in every segment, and that the company is reviewing strategic options for its challenged Patient Care Solutions business.
Key points
- Total orders rose 11.1% organically with a book-to-bill of 1.15 times and backlog of $23.9 billion.
- Results included IEEPA tariff refunds of $129 million for net income and $23 million for adjusted EBIT; adjusted EBIT margin fell 40 basis points to 14.2%, hurt by the Patient Care Solutions decline and memory-chip, oil and freight inflation.
- Patient Care Solutions revenue fell 13.3% to $675 million with segment EBIT of negative $26 million, while Pharmaceutical Diagnostics revenue grew 15.6% and Advanced Imaging Solutions revenue grew 7.9%.
- The company declared a quarterly dividend of $0.035 per share, repurchased 3.3 million shares for $200 million, and received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its second quarter 2026 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.